Although mild in magnitude, significant increases in fasting glucose (Δ= +2.0 mg/dL, 2.6% higher than basal level) and serum leptin levels (Δ= +0.98 ng/mL, 15.4% higher than basal level) were observed in CA patients. The gene discussed is LEP; the disease is cancer.